Optical coherence tomography assessment of axonal and neuronal damage of the retina in patients with familial and sporadic multiple sclerosis

por Grudziecka Pyrek, Monika, Selmaj, Krzysztof
Publicado 2022

Follow-on glatiramer acetate

por Cohen, Jeffrey A., Wolf, Christian, Selmaj, Krzysztof, Arends, Roel
Publicado 2018

The Heat Shock Protein HSP70 Promotes Th17 Genes’ Expression via Specific Regulation of microRNA

por Cwiklinska, Hanna, Cichalewska-Studzinska, Maria, Selmaj, Krzysztof W., Mycko, Marcin P.
Publicado 2020

Impact of Diminished Expression of circRNA on Multiple Sclerosis Pathomechanisms

por Mycko, Marcin P., Zurawska, Anna E., Selmaj, Igor, Selmaj, Krzysztof W.
Publicado 2022

Multiple Sclerosis: circRNA Profile Defined Reveals Links to B-Cell Function

por Zurawska, Anna E., Mycko, Marcin P., Selmaj, Igor, Raine, Cedric S., Selmaj, Krzysztof W.
Publicado 2021

Efficacy and Safety of Proposed Biosimilar Natalizumab (PB006) in Patients With Relapsing-Remitting Multiple Sclerosis: The Antelope Phase 3 Randomized Clinical Trial

por Hemmer, Bernhard, Wiendl, Heinz, Roth, Karsten, Wessels, Hendrik, Höfler, Josef, Hornuss, Cyrill, Liedert, Bernd, Selmaj, Krzysztof
Publicado 2023

Impact of COVID-19 on multiple sclerosis care and management: Results from the European Committee for Treatment and Research in Multiple Sclerosis survey

por Portaccio, Emilio, Fonderico, Mattia, Hemmer, Bernhard, Derfuss, Tobias, Stankoff, Bruno, Selmaj, Krzysztof, Tintorè, Mar, Amato, Maria Pia
Publicado 2021

Pregnancy Experience: Nonclinical Studies and Pregnancy Outcomes in the Daclizumab Clinical Study Program

por Gold, Ralf, Stefoski, Dusan, Selmaj, Krzysztof, Havrdova, Eva, Hurst, Christopher, Holman, Joan, Tornesi, Belen, Akella, Surekha, McCroskery, Peter
Publicado 2016

Characterizing absolute lymphocyte count profiles in dimethyl fumarate–treated patients with MS: Patient management considerations

por Fox, Robert J., Chan, Andrew, Gold, Ralf, Phillips, J. Theodore, Selmaj, Krzysztof, Chang, Ih, Novas, Mark, Rana, Jitesh, Marantz, Jing L.
Publicado 2016

Effects of delayed-release dimethyl fumarate on MRI measures in the Phase 3 DEFINE study

por Arnold, Douglas L., Gold, Ralf, Kappos, Ludwig, Bar-Or, Amit, Giovannoni, Gavin, Selmaj, Krzysztof, Yang, Minhua, Zhang, Ray, Stephan, Monica, Sheikh, Sarah I., Dawson, Katherine T.
Publicado 2014

Magnetization transfer ratio in the delayed-release dimethyl fumarate DEFINE study

por Arnold, Douglas L., Gold, Ralf, Kappos, Ludwig, Bar-Or, Amit, Giovannoni, Gavin, Selmaj, Krzysztof, Yang, Minhua, Zhang, Ray, Stephan, Monica, Sheikh, Sarah I., Dawson, Katherine T.
Publicado 2014

Long-term effects of fingolimod in multiple sclerosis: The randomized FREEDOMS extension trial

por Kappos, Ludwig, O'Connor, Paul, Radue, Ernst-Wilhelm, Polman, Chris, Hohlfeld, Reinhard, Selmaj, Krzysztof, Ritter, Shannon, Schlosshauer, Rolf, von Rosenstiel, Philipp, Zhang-Auberson, Lixin, Francis, Gordon
Publicado 2015

Efficacy of daclizumab beta versus intramuscular interferon beta-1a on disability progression across patient demographic and disease activity subgroups in DECIDE

por Cohan, Stanley, Kappos, Ludwig, Giovannoni, Gavin, Wiendl, Heinz, Selmaj, Krzysztof, Havrdová, Eva Kubala, Rose, John, Greenberg, Steven, Phillips, Glenn, Ma, Wei, Wang, Ping, Lima, Gabriel, Sabatella, Guido
Publicado 2017

Long-term efficacy and safety of three times weekly dosing regimen of glatiramer acetate in relapsing multiple sclerosis patients: Seven-year results of the Glatiramer Acetate Low-...

por Rieckmann, Peter, Zivadinov, Robert, Boyko, Alexey, Selmaj, Krzysztof, Alexander, Jessica K., Kadosh, Shaul, Rubinchick, Svetlana, Bernstein-Hanlon, Emily, Stark, Yafit, Ashtamker, Natalia, Davis, Mat D., Khan, Omar
Publicado 2021

Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis: 3-year results from the SELECTED open-label extension study

por Gold, Ralf, Radue, Ernst-Wilhelm, Giovannoni, Gavin, Selmaj, Krzysztof, Havrdova, Eva, Stefoski, Dusan, Sprenger, Till, Montalban, Xavier, Cohan, Stanley, Umans, Kimberly, Greenberg, Steven J., Ozen, Gulden, Elkins, Jacob
Publicado 2016

Switching from branded to generic glatiramer acetate: 15-month GATE trial extension results

por Selmaj, Krzysztof, Barkhof, Frederik, Belova, Anna N, Wolf, Christian, van den Tweel, Evelyn RW, Oberyé, Janine JL, Mulder, Roel, Egging, David F, Koper, Norbert P, Cohen, Jeffrey A
Publicado 2017

Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients

por Giovannoni, Gavin, Cohen, Jeffrey A., Coles, Alasdair J., Hartung, Hans-Peter, Havrdova, Eva, Selmaj, Krzysztof W., Margolin, David H., Lake, Stephen L., Kaup, Susan M., Panzara, Michael A., Compston, D. Alastair S.
Publicado 2016

Efficacy of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: integrated analysis of the phase 3 trials

por Viglietta, Vissia, Miller, David, Bar-Or, Amit, Phillips, J Theodore, Arnold, Douglas L, Selmaj, Krzysztof, Kita, Mariko, Hutchinson, Michael, Yang, Minhua, Zhang, Ray, Dawson, Katherine T, Sheikh, Sarah I, Fox, Robert J, Gold, Ralf
Publicado 2015

Long-term safety and efficacy of daclizumab beta in relapsing–remitting multiple sclerosis: 6-year results from the SELECTED open-label extension study

por Gold, Ralf, Radue, Ernst-Wilhelm, Giovannoni, Gavin, Selmaj, Krzysztof, Havrdova, Eva Kubala, Montalban, Xavier, Stefoski, Dusan, Sprenger, Till, Robinson, Randy R., Fam, Sami, Smith, Jonathan, Chalkias, Spyros, Giannattasio, Giorgio, Lima, Gabriel, Castro-Borrero, Wanda
Publicado 2020

Improvements in quality of life over 2 years with cladribine tablets in people with relapsing multiple sclerosis: The CLARIFY-MS study

por Brochet, Bruno, Solari, Alessandra, Lechner-Scott, Jeannette, Piehl, Fredrik, Langdon, Dawn, Hupperts, Raymond, Selmaj, Krzysztof, Patti, Francesco, Brieva, Luis, Maida, Eva Maria, Alexandri, Nektaria, Smyk, Andrzej, Nolting, Axel, Keller, Birgit, Montalban, Xavier, Kubala Havrdova, Eva
Publicado 2023